A new study shows that smokers switch to significantly reduce exposure to carcinogenic toxins. This study is available when the skeptics face it.
The study focuses on current smokers, smokers who are smoking at least six months, and former smokers using Nicotine Replacement Therapy (NRT) such as chewing gum and patches. The researchers measured the biomarkers of the participants’ smoking risk.
Some of the most dangerous carcinogens found only a very low level, including tobacco-specific nitrosamines (TSNA) NNAL, a 97% reduction in non-smoking nicotine users. NNAL is associated with several common causes of cancer among smokers.
“The bottom line of this research is that there is no scientific uncertainty now: it becomes safer than smoking”
Measure the presence of Volatile Organic Compounds (VOCs) such as acrolein, with similar results. Acrolein, which is thought to cause lung cancer, was reduced by 67% in non-smoking groups.
Double users – smokers who also banned or used NRT – did not find a significant reduction in many levels of toxins compared to full-time smokers. Only nicotine users who completely abandon cigarettes seem to benefit from vaping.
Professor Peter Hajek of Queen Mary University in London compared this study with the notorious Portland State University study. PSU researchers overheat the nebulizer until they produce formaldehyde and then claim that the scanner may inhale dangerous toxins. “If the electronic liquid is overheated, it may produce high levels of aldehydes,” Hajek said. “The results of the artificial blood presented here, contrary to the results of the frying liquid in the laboratory, show that turning from denaturedness to smoking will not only lead to an increase in aldehyde levels, but will actually be greatly reduced.”
Dr. Michael Siegel of Boston University said more simply. “The bottom line of this research is that there is no scientific uncertainty now: vaping are safer than smoking,” Siegel told the San Diego Union Tribune.
The study was conducted by a group of experienced British and American researchers, including Ann McNeill, co-author of the British Public Health British Electronic Tobacco Examination, and Robert West, a smoking cessation specialist. The main author is Lion Shahab of the University College London. It was funded by a grant from the British Cancer Institute and published in the Journal of Internal Medicine.
One of the authors, Maciej Goniewicz of the Roswell Park Cancer Institute in Buffalo, New York, published a similar study last year. The sample size of the study is small and the method is slightly different, but the results are very close to the existing results.